Key facts
| Price (PPV) | 24.80 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | betamethasoneacide salicylique |
| Class | Corticosteroids, dermatological preparations |
| ATC code | D07XC01 |
| Manufacturer | PHARMA5 |
| Presentation | Tube de 30 g |
| Hospital price | 15.50 MAD |
| Data collected on | 9/8/2026 |
Indications
· Dermatoses corticosensibles à composante kératosique ou squameuse. · Indications privilégiées où la corticothérapie locale est tenue pour le meilleur traitement : o lichénification. · Indications où la corticothérapie est l’un des traitements habituels : o psoriasis, o lichen, o dermite séborrhéique à l’exception du visage. · DIPROSALIC est présenté sous deux formes : o la forme pommade, o la forme lotion plus particulièrement adaptée au traitement des affections du cuir chevelu, des régions pileuses et des plis.
Find an open pharmacy
On-call pharmacies near you
About Skinosalic
Skinosalic belongs to the corticosteroids, dermatological preparations therapeutic class. In Morocco, this drug is marketed by PHARMA5 and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Skinosalic, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Skinosalic
Answers to common questions from Moroccan patients about this drug.